Selected article for: "cancer diabetes and severe infection"
Author: Colombo, Claudia; Garatti, Laura; Ferrante, Giulia; Casadei, Francesca; Montalto, Claudio; Crimi, Gabriele; Cogliati, Chiara; Ammirati, Enrico; Savonitto, Stefano; Morici, Nuccia
Title: Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people
  • Cord-id: insb76x3
  • Document date: 2021_7_28
    • ID: insb76x3
    Snippet: The novel coronavirus disease (COVID-19) has hit the healthcare system worldwide. The risk of severe infection and mortality increases with advancing age, especially in subjects with comorbidities such as cardiovascular disease, hypertension, diabetes, obesity and cancer. Moreover, cardiovascular complications such as myocardial injury, heart failure and thromboembolism are frequently observed in COVID-19 cases, and several biomarkers (troponin, NTproBNP and D-Dimer) have been identified as prog
    Document: The novel coronavirus disease (COVID-19) has hit the healthcare system worldwide. The risk of severe infection and mortality increases with advancing age, especially in subjects with comorbidities such as cardiovascular disease, hypertension, diabetes, obesity and cancer. Moreover, cardiovascular complications such as myocardial injury, heart failure and thromboembolism are frequently observed in COVID-19 cases, and several biomarkers (troponin, NTproBNP and D-Dimer) have been identified as prognostic indicators of disease severity and worst outcome. Currently, there is no specific therapy against SARS-CoV-2, although many medications are under investigation. The aim of this review will be to explore the intertwined relationship between COVID-19 disease and the cardiovascular system, focusing on elderly population. The available supportive treatments along with the related concerns in elderly patients, due to their comorbidities and polypharmacotherapy, will be explored.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and admission cardiac injury: 1, 2, 3
    • acute ards respiratory distress syndrome and lmwh low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and local thrombosis: 1
    • acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute ards respiratory distress syndrome and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute ards respiratory distress syndrome and long duration: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome result and logistic regression: 1, 2
    • acute cardiomyopathy and logistic regression: 1
    • acute cardiomyopathy and low molecular weight: 1
    • acute cardiomyopathy and low molecular weight heparin: 1
    • acute cardiomyopathy and lv dysfunction: 1
    • acute cardiomyopathy and lv systolic: 1
    • acute cardiomyopathy and magnetic resonance: 1
    • acute coronary syndrome and lv dysfunction: 1, 2
    • acute coronary syndrome and lv systolic: 1
    • acute coronary syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10